Fig. 8: Injection of miR-548ag inhibitor and gavage of DPP4 inhibitor were both effective in improving glucose tolerance and insulin sensitivity in mice. | International Journal of Obesity

Fig. 8: Injection of miR-548ag inhibitor and gavage of DPP4 inhibitor were both effective in improving glucose tolerance and insulin sensitivity in mice.

From: miR-548ag promotes DPP4 expression in hepatocytes through activation of TLR(7/8)/NF-κB pathway

Fig. 8: Injection of miR-548ag inhibitor and gavage of DPP4 inhibitor were both effective in improving glucose tolerance and insulin sensitivity in mice.

A Body weight of mice; B ITT and area under the ITT curve for injection of miR-548ag inhibitor and gavage of DPP4 inhibitor; C GTT and area under the GTT curve for injection of miR-548ag inhibitor and gavage of DPP4 inhibitor. (t-test, *P < 0.05, **P < 0.01, ***P < 0.001).

Back to article page